Table 1.
Cell lines | Group | D0 (Gy) | Dq (Gy) | N | SF2 (%) |
---|---|---|---|---|---|
TE-1 | Control | 3.34 ± 0.24 | 1.88 ± 0.17 | 1.76 ± 0.41 | 72.01 ± 2.50 |
siHMGB1 | 2.47 ± 0.31a,* | 1.83 ± 0.11a,* | 2.10 ± 0.38a, * | 69.08 ± 3.70 a,* | |
siHMGB1 + EBSS | 3.55 ± 0.26b,* | 2.58 ± 0.21b,* | 2.07 ± 0.35b,* | 80.11 ± 1.70b,* | |
EBSS | 3.64 ± 0.27 | 2.81 ± 0.18 | 2.16 ± 0.37 | 83.10 ± 1.24 | |
Eca-109 | Control | 3.18 ± 0.19 | 1.47 ± 0.31 | 1.59 ± 0.04 | 70.32 ± 3.30 |
siHMGB1 | 2.48 ± 0.32a,* | 1.44 ± 0.19a,* | 1.79 ± 0.22a, * | 65.71 ± 4.50a,* | |
siHMGB1 + EBSS | 3.88 ± 0.41b,* | 2.00 ± 0.23b, * | 1.66 ± 0.33b, * | 75.11 ± 2.90b,* | |
EBSS | 3.98 ± 0.26 | 2.38 ± 0.21 | 1.82 ± 0.39 | 78.14 ± 1.40 |
Note: Radiobiological parameters (D0, Dq, N and SF2) were calculated from the single-hit multitarget model (SF = 1−(1−e^ [−kD]) ^N) using GraphPad Prism 7.0
D0: final slope; Dq: quasi-threshold dose; N: extrapolation number; SF2: survival fraction of 2 Gy
*P < 0.05, t test
asiHMGB1 vs. control
bsiHMGB1 + EBSS vs. siHMGB1